SIRT4, that besides other targets, inhibits PDH (pyruvate dehygrogenase) 9 and GDH (glutamate dehydrogenase) 10 as key anaplerotic enzymes feeding into the citric acid cycle, represents a metabolic tumor suppressor that is down-regulated in many cancer types. Here, SIRT4 is linked to neoplasm.